Cellular immune response to marburg virus infection in cynomolgus macaques

Viral Immunology

Volumn 21, Issue 3, 2008, Pages 355-363

  Fritz, Elizabeth A ^a   Geisbert, Joan B ^b   Geisbert, Thomas W ^b   Hensley, Lisa E ^a   Reed, Douglas S ^c  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD123 ANTIGEN; CYTOKINE; GLYCOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; B LYMPHOCYTE; BLOOD ANALYSIS; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; IMMUNITY; INNATE IMMUNITY; LEUKOCYTE; MACACA; MARBURG VIRUS; NATURAL KILLER CELL; NONHUMAN; SPLEEN; VIRUS HEMORRHAGIC FEVER; VIRUS STRAIN;

ANIMALS; B-LYMPHOCYTES; BLOOD; CYTOKINES; DENDRITIC CELLS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MACACA; MARBURG VIRUS DISEASE; MARBURGVIRUS; SPLEEN; T-LYMPHOCYTE SUBSETS;

LAKE VICTORIA MARBURGVIRUS; MACACA; PRIMATES;

EID: 51849118445     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2008.0023     Document Type: Conference Paper

References (40)

1. Jahrling PB: Filoviruses and arenaviruses. In: Manual of Clinical Microbiology. (Murray PR, Baron EJ, Pfaller M, Tenover FC, and Yolken RH, ed.). Washington: ASM Press, 1999, pp. 1125-1136.
2. Khan AS, Sanchez A, and Pflieger AK: Filoviral haemorrhagic fevers. Br Med Bull 1998;54:675-692.
3. Sanchez AS, Khan AS, Zaki SR, Nabel GJ, Ksiazek TG, and Peters CJ: Filoviridae: Marburg and Ebola viruses. In: Fields Virology, 4th ed. (Knipe DM, and Howley PM, ed.). Philadelphia: Lippincott Williams & Wilkins, 2001, pp. 1279-1304.
4. Geisbert TW, and Jahrling PB: Exotic emerging viral diseases: progress and challenges. Nat Med 2004;10:S110-S121.
5. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, et al.: Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 2006;355:909-919.
6. Feldmann H, Geisbert TW, Jahrling PW, et al.: In: Virus Taxonomy: VIIIth Report of the International Committee on Taxonomy of Viruses. (Fauquet C, Mayo MA, Maruloff M, Desselberger U, and Ball LA, eds.). London: Elsevier/Academic, 2004, pp. 645-653.
7. New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule. Fed Regist 2002;67:37988-37998.
8. Gonchar NI, Pshenichnov VA, Pokhodiaev VA, Lopatov KL, and Firsova IV: [The sensitivity of different experimental animals to the Marburg virus]. Vopr Virusol 1991;36:435-437.
9. Siegert R, Shu HL, Slenczka W, Peters D, and Muller G: [On the etiology of an unknown human infection originating from monkeys]. Dtsch Med Wochenschr 1967;92:2341-2343.
10. Johnson ED, Johnson BK, Silverstein D, et al.: Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Suppl 1996;11:101-114.
11. Murphy FA, Simpson DI, Whitfield SG, Zlotnik I, and Carter GB: Marburg virus infection in monkeys. Ultrastructural studies. Lab Invest 1971;24:279-291.
12. Villinger F, Rollin PE, Brar SS, et al.: Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 1999;179(Suppl 1):S188-S191.
13. Hensley LE, Young HA, Jahrling PB, and Geisbert TW: Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 2002;80:169-179.
14. Bray M, and Geisbert TW: Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005;37:1560-1566.
15. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, and Jahrling PB: Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000;80:171-186.
16. Baize S, Leroy EM, Georges-Courbot MC, et al.: Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999;5:423-426.
17. Reed DS, Hensley LE, Geisbert JB, Jahrling PB, and Geisbert TW: Depletion of peripheral blood T lymphocytes and NK cells during the course of Ebola hemorrhagic fever in cynomolgus macaques. Viral Immunol 2004;17:390-400.
18. Esmon CT: Inflammation and thrombosis. J Thromb Haemost 2003;1:1343-1348.
19. Geisbert TW, Hensley LE, Larsen T, et al.: Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003;163:2347-2370.
20. Schnittler HJ, and Feldmann H: Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages? Clin Infect Dis 1998;27:404-406.
21. Siegal FP, Kadowaki N, Shodell M, et al.: The nature of the principal type 1 interferon-producing cells in human blood. Science 1999;284:1835-1837.
22. Kash JC, Muhlberger E, Carter V, et al.: Global suppression of the host antiviral response by Ebola- and Marburg viruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J Virol 2006;80:3009-3020.
23. Reid SP, Leung LW, Hartman AL, et al.: Ebola virus VP24 binds karyopherin a1 and blocks STAT1 nuclear accumulation. J Virol 2006;80:5156-5167.
24. Cardenas WB, Loo YM, Gale M, et al.: Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol 2006;80:5168-5178.
25. Grosch M, Kash J, and Muhlberger E: Interference of Marburg and Ebola viruses with the type I IFN response: induction and signalling. In: XIIIth International Conference on Negative Strand Viruses. Salamanca, Spain, 2006.
26. Szotowski B, Antoniak S, Poller W, Schultheiss HP, and Rauch U: Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005;96:1233-1239.
27. Bouwman JJ, Visseren FL, Bosch MC, Bouter KP, and Diepersloot RJ: Procoagulant and inflammatory response of virusinfected monocytes. Eur J Clin Invest 2002;32:759-766.
28. Geisbert TW, Hensley LE, Jahrling PB, et al.: Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet 2003;362:1953-1958.
29. Takada A, Ebihara H, Jones S, Feldmann H, and Kawaoka Y: Protective efficacy of neutralizing antibodies against Ebola virus infection. Vaccine 2007;25:993-999.
30. Ito H, Watanabe S, Takada A, and Kawaoka Y: Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J Virol 2001;75:1576-1580.
31. Parren PW, Geisbert TW, Maruyama T, Jahrling PB, and Burton DR: Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J Virol 2002;76:6408-6412.
32. Maruyama T, Rodriguez LL, Jahrling PB, et al.: Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol 1999;73:6024-6030.
33. Jones SM, Feldmann H, Stroher U, et al.: Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 2005;11:786-790.
34. Sullivan NJ, Geisbert TW, Geisbert JB, et al.: Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 2003;424:681-684.
35. Gupta M, Greer P, Mahanty S, et al.: CD8-mediated protection against Ebola virus infection is perforin dependent. J Immunol 2005;174:4198-4202.
36. Blue ML, Daley JF, Levine H, and Schlossman SF: Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J Immunol 1985;134:2281-2286.
37. + T lymphocytes in cynomolgus monkeys. Dev Comp Immunol 1998;22:239-248.
38. Weiss L, Roux A, Garcia S, et al.: Persistent expansion, in a human immunodeficiency virus-infected person, of V beta-restricted CD4+CD8+ T lymphocytes that express cytotoxicity-associated molecules and are committed to produce interferon-gamma and tumor necrosis factor-alpha. J Infect Dis 1998;178:1158-1162.
39. Nascimbeni M, Shin EC, Chiriboga L, Kleiner DE, and Rehermann B: Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. Blood 2004;104:478-486.
40. Nam K, Akari H, Terao K, Shibata H, Kawamura S, and Yoshikawa Y: Peripheral blood extrathymic CD4(+)CD8(+) T cells with high cytotoxic activity are from the same lineage as CD4(+)CD8(-) T cells in cynomolgus monkeys. Int Immunol 2000;12:1095-1103.